“The digital biomarker space in general is advancing very rapidly, which is great news for patients and researchers. As a researcher, l’ve had trouble in both finding CNS-relevant digital tools, and in determining how well developed and validated they are. Many companies that provide tools like this don’t share validation evidence in a single place – it’s often scattered across papers, posters, press releases, clinicaltrials.gov – or just not available online. I’ve done plenty of manual literature reviews over the years to aggregate this information, but it’s a very time-consuming process, and the output quickly goes out of date. The DiMe digital measurement products library provides a centralized, unified platform for this material, which will make digital biomarker selection much easier – hopefully leading to accelerated development of treatments for patients.”